<--- Back to Details
First PageDocument Content
Pharmacology / Leflunomide / Rheumatoid arthritis / Adalimumab / Infliximab / Disease-modifying antirheumatic drug / Certolizumab pegol / Biologic / Rheumatology / Immunosuppressants / Medicine / Immunology
Date: 2013-12-04 21:16:15
Pharmacology
Leflunomide
Rheumatoid arthritis
Adalimumab
Infliximab
Disease-modifying antirheumatic drug
Certolizumab pegol
Biologic
Rheumatology
Immunosuppressants
Medicine
Immunology

Oral Oncology Referral Form

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Download Document from Source Website

File Size: 79,79 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document